Michal Melamed is a Dialysis and Renal Disease Management physician affiliated with NYU Langone Health. OpenAlex indexes 202 publications with 11,734 citations (h-index 53); ClinicalTrials.gov lists 3 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Nephrology profiles in the FindMyKOL directory.
Data verified 21 Oct 2026
Overview
Updated 28 Oct 2026
Michal Melamed, MD, is affiliated with NYU Langone Health. The public record shows 202 publications with 11,734 citations (h-index 53), centered on Dialysis and Renal Disease Management, Chronic Kidney Disease and Diabetes, Parathyroid Disorders and Treatments. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 1 companies, 11 NIH-funded awards (2007–2026).
- Most recent indexed publication: 2026 · Journal of the American Society of Nephrology
- Top research focus: Dialysis and Renal Disease Management
- 3 registered trials on ClinicalTrials.gov
- Open Payments reporting from 1 companies
Generated from the cited public record · current as of 28 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 11 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 112.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 28 Oct 2026
Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:
- Interventions for Promoting Kidney Transplant Empowerment
Sponsor: Icahn School of Medicine at Mount Sinai
- Effects of Vitamin D and Fish Oil on the Kidney in Hypertensives
Sponsor: Albert Einstein College of Medicine
- The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney Disease
Sponsor: Albert Einstein College of Medicine
Industry payments
Updated 28 Oct 2026
1 company reported payments to CMS in program years 2025–2025. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20251 payment
NIH funding
Updated 28 Oct 2026
11 NIH research awards on record, funded 2007–2026 per NIH RePORTER. The latest:
- CTSA K12 Program at New York University
New York University School of Medicine
FY2026$1,570,668K12TR005770 - INSPIRE: INterventionS for Promoting kIdney tRansplant Empowerment
Icahn School of Medicine at Mount Sinai
FY2026$836,530U01DK137259 - Community Health Workers in an Interdisciplinary Outpatient CKD Clinic to Optimize Social Care Navigation, Patient Engagement, and Home Dialysis Utilization- the CHOOSE Home trial
Albert Einstein College of Medicine
FY2026$504,154R01DK140574
Congress activity
Updated 28 Oct 2026
1 congress contribution (2020) across ADA per OpenAlex. The most recent:
- 1061-P: Effects of Long-Term Vitamin D and Omega-3 Fatty Acid Supplementation on Inflammatory and Cardiac Biomarkers in Patients with Type 2 Diabetes
ADA Scientific Sessions
ADA2020Co-authorPoster
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 28 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Glucosuria as a Marker of Adherence to Sodium-Glucose Cotransporter 2 Inhibitors and Clinical Outcomes in Real-World Practice.
Journal of the American Society of Nephrology
Article2026 - Authors' Reply: Peer Mentorship's Paradox in Dialysis: Neutral Overall but Lifesaving for Black Patients: Toward Equity-Driven Trial Designs.
Journal of the American Society of Nephrology
Article2025 - Effect of Peer Mentorship on Hospitalizations among Patients Receiving Maintenance Hemodialysis: A Pragmatic Randomized Controlled Trial.
Journal of the American Society of Nephrology
Article2025
Most-cited works
by citation count (OpenAlex)- 0125-Hydroxyvitamin D Levels and the Risk of Mortality in the General PopulationArticle1,218 citations2008
- 02Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the USArticle956 citations2020
- 03Prevalence and Associations of 25-Hydroxyvitamin D Deficiency in US Children: NHANES 2001–2004Article623 citations2009
- 04
- 05
Network
Updated 28 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 28 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
nyulangone.org/doctors/1407953235/michal-l-melamed
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Gareth Morgan, MD
NYU Langone Health
Nathan Levin, MD
NYU Langone Health
Ira Jacobson, MD
NYU Langone Health
Michael Zelefsky, MD
NYU Langone Health
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Toni Choueiri, MD
Dana-Farber Cancer Institute
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Fred Saad, MD
Centre hospitalier de l'Université de Montréal (CHUM)